| Status |
Description | Section |
| RED | Avacopan Tavneos® (10mg capsules) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Dimethyl fumarate 120mg & 240mg Tecfidera® (Capsules) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Diroximel fumarate Vumerity® (231 mg gastro-resistant hard capsules) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Fingolimod 500microgram (Capsules) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Isatuximab SARCLISA® (20mg/mL concentrate for solution for infusion) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Lenalidomide | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Mogamulizumab Poteligeo ® (4 mg/mL concentrate for solution for infusion.) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Nivolumab Opdivo® (10mg/1mL concentrate for solution for infusion) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Nivolumab / Relatlimab Opdualag® (240 mg/80 mg concentrate for solution for infusion) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Ocrelizumab Ocrevus® (Infusion) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Pomalidomide Imnovid® | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Ponesimod Ponvory® (20 mg tablets) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Siponimod Mayzent® (0.25mg and 2 mg film-coated tablets) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Teriflunomide Aubagio® | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Thalidomide Pharmion® | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |
| RED | Ublituximab Briumvi® (150 mg concentrate for solution for infusion) | Malignant disease and immunosuppression, Other immunomodulating drugs, 08.02.04 |